News
-
Trojan Horse for KSHV
The studies performed by Dr. Inagaki is press released at UC Davis Cancer Center website. The study designed a gene therapy, which expresses therapeutic gene selectively in KSHV infected cells.
-
Our studies were highigted at UC Davis Cancer Center Website
Dr. Izumiya’s researches were introduced at UC Davis Cancer Center Website, which highlighted significance of basic science.
-
Deregulation of Monocytes by KSHV Infection
The studies conducted by Dr. Shimoda was press released at the UC Davis Medical school website. The study highlights clever strategy established by KSHV encoded IL-6.
-
Discovery of cell protein that keeps Kaposi’s sarcoma herpesvirus
Dr. Izumiya’s research team revealed a key cellular protein, which a herpesvirus uses to maintain silent infection to hide from the host immune system. Another essential viral-host protein interaction was identified.
-
A viral decoy blocks cancer cell proliferation
The study was published in Communications of Biology and introduced by Drug Discovery News. Viruses outsmart host cells. The cartoon shows virus beads cancers.
-
A baby step toward a product
Dr. Izumiya’s research team is awarded seed funding from the STAIR (Science Translation and Innovation Research) program for the Development of a Novel Cancer Drug from a Viral Protein Sequence.